130 related articles for article (PubMed ID: 98364)
1. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Balant L
Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
[No Abstract] [Full Text] [Related]
2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
3. Glipizide: experimental study and comparison with other sulfonylureas.
Loubatieres-Mariani MM
Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
[No Abstract] [Full Text] [Related]
4. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
5. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
6. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
[No Abstract] [Full Text] [Related]
8. Oral hypoglycemic agents in the treatment of type II diabetes.
Tal A
Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of sulfonylureas.
Skillman TG; Feldman JM
Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of sulfonylureas: a brief review.
Melander A; Wåhlin-Boll E
Ann Clin Res; 1983; 15 Suppl 37():12-5. PubMed ID: 6679185
[TBL] [Abstract][Full Text] [Related]
11. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
12. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
Pettipierre B; Fabre J
Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
[No Abstract] [Full Text] [Related]
13. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
14. [Kinetic aspects of the glipizide-induced hypoglycemia in the dog (author's transl)].
Blayac JP; Ribes G; Valette JF; Loubatières-Mariani MM
J Pharmacol; 1980; 11(4):463-72. PubMed ID: 7206734
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
16. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
Ochi H; Ikeda T
Nephron; 1999 Jan; 81(1):67-71. PubMed ID: 9884422
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypoglycemic sulfonylureas on hepatic fructose metabolism in the rat.
Schönborn J; Poser W; Panten U; Hasselblatt A
Horm Metab Res; 1974 Jul; 6(4):284-3. PubMed ID: 4213055
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of glipizide.
Melander A; Wåhlin-Boll E
Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
[TBL] [Abstract][Full Text] [Related]
19. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
20. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
